Projected increase in amyotrophic lateral sclerosis from 2015 to 2040.

Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ. · 2016

Read Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. by Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4987527.txt.

Introduction

Karissa C. Arthur and five co-authors project the global growth of amyotrophic lateral sclerosis to 2040. Their study appeared in Nature Communications in 2016. ALS is rare, a fatal disease of motor neurons, but its care costs and family burden are heavy. Planning services needs a forecast. The team combined disease rates with United Nations population projections, country by country, to estimate future case counts.

Worldwide cases rise from about two hundred and twenty-three thousand in 2015 to about three hundred and seventy-seven thousand in 2040. That is an increase of about sixty-nine percent. Population aging drives nearly all of it, above all in developing nations where the share of older people climbs fastest. The authors warn the count is likely an underestimate as health care and economies improve and more cases get diagnosed. They offer the numbers for health policy planning.

Catalog record

CREATORArthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4987527

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Projected increase in amyotrophic lateral sclerosis from 2015 to 2040 By Karissa C. Arthur, Andrea Calvo, T. Ryan Price, Joshua T. Geiger, Adriano Chiò, Bryan J. Traynor Published in: Nature Communications DOI: 10.1038/ncomms12408 ABSTRACT Although amyotrophic lateral sclerosis (ALS) is relatively rare, the socioeconomic significance of the disease is extensive. It is therefore vital to project the epidemiologic trend of ALS. To date, there have been few published studies attempting to estimate the number and distribution of ALS cases in the upcoming years. Here we show that the number of ALS cases across the globe will increase from 222,801 in 2015 to 376,674 in 2040, representing an increase of 69%. This increase is predominantly due to ageing of the population, particularly among developing nations. This projection is likely an underestimate due to improving healthcare and economic conditions. The results should be used to inform healthcare policy to more efficiently allocate healthcare resources. According to the United Nations, the number of individuals in the world above age 60 is expected to increase rapidly. This ageing pattern is especially significant in developing countries, where the proportion of older individuals will increase from about 9% in 2015 to 16% by 2040 (ref. 1). The number of individuals diagnosed with chronic disease has grown due to this trend2. For instance, one study found that the number of individuals with Parkinson's disease will double between 2005 and 2030, and the weight of disease will shift from developed nations to developing nations3. While similar studies have been conducted on other diseases45, no such study has sought to project the number of amyotrophic lateral sclerosis (ALS) cases. ALS is the most common adult-onset motor neuron disease. It is characterized by both upper and lower motor neuron degeneration and has a median survival of 2–4 years6. The worldwide annual incidence of ALS is about 1.9 per 100,000 (ref. 7), with uniform rates in Caucasian populations and lower rates in African, Asian and Hispanic populations8. Although rare, the socioeconomic significance of the disease is substantial910. Accurate projections of ALS case numbers will help guide healthcare policy and the effective allocation of resources. The objective of our study is to estimate the number of individuals with ALS across the globe in the years 2015 and 2040. To do this, we use previously published data on the incidence of ALS. We show that the number of cases of this fatal neurodegenerative disease will increase by 69% over the next 25 years and that this increase is primarily due to population ageing. We further demonstrate an overall shift in the projected number of ALS cases away from developed countries towards more developing nations. RESULTS Population and ALS prevalence estimates We identified ALS incidence studies for 10 countries and geographical regions (China, Europe, Iran, Japan, Libya, New Zealand, Serbia, Taiwan, the United States and Uruguay) that were suitable for analysis. The total population of these countries in 2015 was 2.46 billion, representing 34% of the world population. The total population of the countries above age 20 will increase by 7.7% from 1.89 billion in 2015 to 2.03 billion in 2040. The prevalence rates of ALS were highest in Uruguay, New Zealand and the United States, and lowest in Serbia, China and Taiwan (Supplementary Tables 1 and 2). The age groups with the highest prevalence rates of ALS were from age 60 to 79. Estimates of ALS case numbers in 10 regions In 2015, there were 45,810 men and 34,352 women diagnosed with ALS in the 10 regions for which incidence rates were available. The projected number of individuals with ALS in 2040 was 60,394 men and 45,299 women. Thus, the total number of individuals with ALS is expected to grow from 80,162 in 2015 to 105,693 in 2040, representing an increase of >31% (Table 1). The geographical distribution of this increase in case numbers is shown in Fig. 1. The number of ALS cases will increase substantially in the developing world over the next 25 years (Fig. 2). Notably, developing countries (China, Iran, Libya, Serbia, Taiwan and Uruguay) will see a 50% increase in the number of ALS cases from 2015 to 2040. In contrast, cases in developed countries (Europe, Japan, New Zealand and the United States) will increase by only 24% during the same time period. The net result of this pattern is that the weight of disease will gradually shift from developed countries to developing countries. For instance, in 2015, the developed countries studied accounted for 71% of ALS cases, but this will drop to 67% by 2040. This trend is most notable in Iran and Libya, where the number of individuals with ALS in each country will more than double over this time period. Estimate of global ALS case numbers To estimate the number of cases across the world, incidence rates obtained from countries were applied to the population of each country's respective continent. Incidence rates for the United States were used for North America, Uruguay for South America, Libya for Africa and New Zealand for Oceania. Incidence rates from China, Japan, Taiwan and Iran were weighted according to the size of the study population and applied to Asia. European cases were estimated using incidence rates from the European pooled analysis. By our estimates, the number of cases of ALS in the world will increase from 222,801 in 2015 to 376,674 in 2040, representing an increase of 69%. The largest increase will be seen in Africa with 116%, followed by Asia with 81% and South America with 73%. Meanwhile, the population over the age of 20 in these regions will increase by only 33% over the same time period. DISCUSSION The number of individuals with ALS in the 10 studied countries and regions is expected to increase by nearly one third from 80,162 in 2015 to 105,693 in 2040. A growing population size cannot solely explain this increase. While the number of individuals over the age of 20 living in these countries will increase by only 7.7%, the number of individuals with ALS will increase by 31%. Instead, the observed expansion in ALS cases is most likely due to ageing of the populations of these countries that leads to an increase in the number of individuals in the age groups most at risk of developing ALS (60–79 years of age)1. Population ageing may also explain our projection that the weight of ALS will shift from developed countries to developing countries. The adult population in developing countries will increase by only 7.6%, but the number of ALS cases will increase by over 50%. This is most likely due to the rapid ageing of these populations (Fig. 3)1. A recent review indicates that the standardized total annual cost per patient with ALS was $69,475 in the United States, $59,018 in Spain, $47,092 in Germany, $21,732 in the Netherlands and $11,251 in Greece11. There are currently no studies outlining the cost of ALS in developing countries, and while economic costs are most likely lower in these locations, the increase in ALS cases will place an immense burden on their healthcare systems in the coming decades. The data for ALS are similar to the projected trend of Parkinson's disease where the number of individuals

Read the complete text